Written answers
Tuesday, 27 March 2012
Department of Health
Vaccination Programme
4:00 pm
Michael Healy-Rae (Kerry South, Independent)
Link to this: Individually | In context
Question 651: To ask the Minister for Health the position regarding the safety of the flu vaccine Pandemrix; if it is actually in the public interest; his views on whether it should be banned; and if he will make a statement on the matter. [16973/12]
James Reilly (Dublin North, Fine Gael)
Link to this: Individually | In context
Pandemrix is licensed for use across the EU by the European Medicines Agency for prevention of influenza caused by the H1N1 influenza virus.
The indications for Pandemrix changed following an EU review of concerns about a link between vaccination with Pandemrix and narcolepsy in children and adolescents. This resulted in a recommendation that Pandemrix should only be used in people under 20 years of age unless the annual seasonal trivalent influenza vaccine is not available, and if immunisation against H1N1 is still required, for instance in people at risk of the complications of infection.
The HSE has not recommended use of Pandemrix in Ireland since early 2011, when GPs were advised to return any remaining stocks to the HSE for disposal.
No comments